Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Christian Behrenbruch

Aussie cancer diagnosis firm expands with $3.3b merger

Telix Pharmaceuticals will acquire a German radioisotope manufacturer, giving it greater control of its isotope supply it is using in cancer treatment.

AAP · Sep 21

Telix Pharmaceuticals Enters Q4 On Strong Footing With Stabilized Pricing Pressures, Upgraded Annual Sales Guidance

Telix Pharmaceuticals (NASDAQ:TLX) updated on Tuesday its commercial and operational performance for the third quarter of fiscal 2025.

Benzinga · Oct 14, 2025

Iron ore rally helps lead Australian shares higher

The ASX200 index finished up almost 0.5 per cent, with the heavyweight mining sector climbing the most on a jump in Chinese demand.

AAP · Jan 14, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Aussie shares drop from peak but finish week higher

The ASX200 has dropped 0.9 per cent, giving back most of the previous day's gains, but has finished the week 0.8 per cent higher.

AAP · Oct 18, 2024

Aussie shares dip slightly, ending 10-day win streak

The ASX200 has finished three points lower, just enough to snap its longest winning streak since early-2015.

AAP · Aug 23, 2024

Telix posts first profit as sales triple to $502m

Melbourne-based radiation oncology business Telix Pharmaceuticals has made its first-ever profit after strong sales for its prostate cancer imaging agent.

AAP · Feb 23, 2024

Coverage From

People

Joanna Kordina

22 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the US Food and Drug Administration

Corporate Travel Management

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.